Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiosome Perfusion After Tibial Bypass
NCT03012750Phase 2Completed
- Sponsor
- University Hospital Erlangen
- Start
- Feb 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of indocyanine green in Peripheral Arterial Disease (PAD), sponsored by University Hospital Erlangen. Started Feb 2015; status: completed.
02
Drugs
indocyanine green
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT03012750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012750.